UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 05,
Plus Therapeutics (NASDAQ:PSTV)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Plus Therapeutics Charts.
Plus Therapeutics (NASDAQ:PSTV)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Plus Therapeutics Charts.

Plus Therapeutics, Inc. News

Plus Therapeutics Announces Private Placement Financing of up to $18 Million
Monday 6 May 2024 (6 hours ago) • GlobeNewswire Inc.
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense
Monday 22 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

More Plus Therapeutics, Inc. News Articles